RAD011

cannabidiol · Radius Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RAD011, covering 2022-10-06 to 2023-10-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome [Phase 2, Phase 3]

See pricing